About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Daily Tadalafil in Diabetic ED Patients | Clinical Trials | Clareo Health

Back to clinical trial search

Not Yet RecruitingNANCT06962462

Daily Tadalafil in Diabetic ED Patients

This study evaluates the effect of 5 mg daily tadalafil therapy on serum levels of Endothelin-1 and E-selectin in diabetic male patients with erectile dysfunction. Outcomes will be compared pre- and p...

Lead sponsor: South Valley University•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Ahmed K Abdelmawgoud, M.Sc

CONTACT

01066152814 amed66177@gmail.com

Sponsors

Lead Sponsor

South Valley University

Age

30 - 60 years

Sex

MALE

Healthy Volunteers

Yes

Inclusion Criteria

•Male patients aged between 30 and 60 yearsز Diagnosed with diabetes mellitus Suffering from erectile dysfunction No history of hypertension or other systemic diseases

Exclusion Criteria

•History of pelvic trauma or major pelvic surgery Pacientes con hipogonadismo o hiperprolactinemia Chronic liver disease or cardiovascular disorders Chronic use of central nervous system drugs, anti-androgenic drugs, or Tramadol Smokers Non-vasculogenic erectile dysfunction Known allergy to tadalafil

Related studies

Regenerative Injection of Stem Cells or Stem Cell-derived Exosomes for Erectile Dysfunction (RISE)

NCT06605508 · Erectile Dysfunction, Erectile Dysfunction Associated With Type 2 Diabetes Mellitus, and more

Enrolling By InvitationNA

Platelet Rich Plasma (PRP) as Terapeutical Option in Erectil Disfunction (DE)

NCT06768177 · Erectile Dysfunction Due to General Medical Condition, Erectile Dysfunction Following Radical Prostatectomy, and more

A Tissue Sparing, Laser Assisted Penile Prosthesis Implantation Technique

NCT06743048 · Erectile Dysfunction, Erectile Dysfunction Associated With Type 2 Diabetes Mellitus, and more

COMPLETEDPhase 1

Safety of Wharton Jelly in Erectile Dysfunction

NCT02945449 · Erectile Dysfunction Associated With Type 2 Diabetes Mellitus

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 8, 2025Terms

Trial snapshot

StatusNOT_YET_RECRUITING

PhaseNA

Enrollment60

Start dateMay 2025

Last updatedMay 8, 2025

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 8, 2025Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions